Russell Investments Group Ltd. Decreases Stock Position in LHC Group, Inc. (NASDAQ:LHCG)

Russell Investments Group Ltd. lowered its stake in LHC Group, Inc. (NASDAQ:LHCG – Get Rating) by 17.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 66,169 shares of the health services provider’s stock after selling 14,338 shares during the period. Russell Investments Group Ltd. owned approximately 0.21% of LHC Group worth $11,153,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. BCK Capital Management LP purchased a new position in LHC Group during the 1st quarter valued at about $1,307,000. Advisor Group Holdings Inc. increased its holdings in LHC Group by 15.6% during the 1st quarter. Advisor Group Holdings Inc. now owns 8,925 shares of the health services provider’s stock valued at $1,497,000 after purchasing an additional 1,205 shares during the period. Wolverine Asset Management LLC purchased a new position in LHC Group during the 1st quarter valued at about $421,000. Ziegler Capital Management LLC increased its holdings in LHC Group by 2.4% during the 1st quarter. Ziegler Capital Management LLC now owns 48,369 shares of the health services provider’s stock valued at $8,155,000 after purchasing an additional 1,133 shares during the period. Finally, Precision Wealth Strategies LLC purchased a new position in LHC Group during the 1st quarter valued at about $387,000. Hedge funds and other institutional investors own 89.65% of the company’s stock.

LHC Group Stock Performance

Shares of LHC Group stock opened at $161.79 on Friday. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $5.02 billion, a P/E ratio of 68.27, a P/E/G ratio of 2.49 and a beta of 0.48. The business has a fifty day simple moving average of $161.14 and a two-hundred day simple moving average of $152.91. LHC Group, Inc. has a 12 month low of $108.42 and a 12 month high of $192.92.

LHC Group (NASDAQ:LHCG – Get Rating) last posted its quarterly earnings results on Wednesday, May 4th. The health services provider reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.04. The firm had revenue of $571.50 million during the quarter, compared to analyst estimates of $573.10 million. LHC Group had a return on equity of 8.87% and a net margin of 3.20%. LHC Group’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.39 EPS. On average, equities analysts forecast that LHC Group, Inc. will post 5.84 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on LHCG shares. Deutsche Bank Aktiengesellschaft downgraded LHC Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $190.00 to $170.00 in a report on Monday, April 25th. Barclays raised their target price on LHC Group from $154.00 to $170.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 12th. Twelve analysts have rated the stock with a hold rating, According to data from MarketBeat, LHC Group currently has an average rating of “Hold” and a consensus target price of $167.33.

About LHC Group

(Get Rating)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).